share_log

南新制药(688189.SH):拟对募投项目“创新药研发项目”的“帕拉米韦吸入溶液”项目的预计完成时间进行调整

Hunan Nucien Pharmaceutical Co., Ltd. (688189.SH): Plans to adjust the expected completion time of the "Innovative Drugs Research and Development Project" for the "Peramivir Inhalation Solution" project.

Gelonghui Finance ·  Dec 11, 2024 18:30

On December 11, Glonghui reported that Hunan Nucien Pharmaceutical Co., Ltd. (688189.SH) announced that the company intends to adjust the expected completion date of the fundraising investment project "Innovative Drugs Research and Development Project" for the "Peramivir Inhalation Solution" project, under the premise that there are no changes to the project implementation entity, implementation method, and use of raised funds, with the scheduled usable status date set for December 31, 2026.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment